valine and Encapsulating Peritoneal Sclerosis

valine has been researched along with Encapsulating Peritoneal Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chiu, YH; Hsu, BG; Ke, CY; Lee, CJ; Lin, NT; Subeq, YM	1

Other Studies

1 other study(ies) available for valine and Encapsulating Peritoneal Sclerosis

Article	Year
Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats. Cytokine, 2011, Volume: 53, Issue:2 Topics: Animals; Blood Pressure; Chlorhexidine; Glucose; Heart Rate; Immunohistochemistry; Liver Cirrhosis; Male; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Protective Agents; Rats; Rats, Sprague-Dawley; Staining and Labeling; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan	2011

Article

Year

Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.

Cytokine, 2011, Volume: 53, Issue:2

Topics: Animals; Blood Pressure; Chlorhexidine; Glucose; Heart Rate; Immunohistochemistry; Liver Cirrhosis; Male; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Protective Agents; Rats; Rats, Sprague-Dawley; Staining and Labeling; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan

2011